日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tunable Wavelength-Multiplexed Dual-Frequency Bound Pulse in a Carbon-Nanotube-Based Fiber Laser

基于碳纳米管光纤激光器的可调谐波长复用双频束缚脉冲

Wang, Lin; Hu, Guoqing; Wang, Yan; Chen, Guangwei; Xuan, Liang; Zhou, Zhehai; Yu, Jun

SAFFRON-301: a randomised phase III study of sitravatinib in combination with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer

SAFFRON-301:一项随机III期研究,评估sitravatinib联合tislelizumab治疗局部晚期或转移性非小细胞肺癌患者的疗效

Zhou, Qing; Gao, Bo; Hu, Jie; Zhao, Jun; Wang, Mengzhao; He, Kai; Zhang, Wei; Liu, Chunling; Fang, Jian; Li, Xing Ya; Wang, Zhehai; Matos, Marco; Kwatra, Vineet; Zheng, Wenjuan; Wang, Chenyang; Chen, Yaxi; Zhang, Juan; Wang, Jun; Wu, Yi-Long

Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial

阿特珠单抗联合贝伐珠单抗和化疗治疗转移性非鳞状非小细胞肺癌:随机双盲3期IMpower151试验

Zhou, Caicun; Dong, Xiaorong; Chen, Gongyan; Wang, Zhehai; Wu, Xianghua; Yao, Yu; Zhang, Yiping; Cheng, Ying; Pan, Hongming; Zhang, Xiaodong; Cui, Jiuwei; Wang, Lifeng; Chen, Xi; Li, Xiaoling; Wang, Ziping; Wang, Qiming; He, Jianxing; Wang, Mengzhao; Yan, Iris; Qian, Li; Xu, Miao; Huang, Xiayu; Sun, Chun; Cai, Jun; Wu, Qiong; Ballinger, Marcus; Kaul, Monika; Srivastava, Minu K

Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients With Advanced NSCLC Who Received Pretreatment With EGFR-TKIs (ML41256): A Multicenter, Prospective, Single-Arm, Phase 2 Trial

阿特珠单抗联合贝伐珠单抗治疗既往接受过 EGFR-TKI 治疗的晚期 NSCLC 患者的疗效和安全性 (ML41256):一项多中心、前瞻性、单臂 II 期试验

Fang, Wenfeng; Fang, Jian; Tian, Panwen; Fan, Yun; Yu, Qitao; Zhang, Xiaochun; Wang, Zhehai; Liu, Xiaoyuan; Shi, Yanjun; Zhang, Li

Dynamics of h-Shaped Pulse to GHz Harmonic State in a Mode-Locked Fiber Laser

锁模光纤激光器中h形脉冲到GHz谐波态的动态过程

Wang, Lin; Hu, Guoqing; Wang, Yan; Chen, Guangwei; Xuan, Liang; Zhou, Zhehai; Yu, Jun

Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial

信迪利单抗联合安罗替尼和化疗作为广泛期小细胞肺癌二线或后续治疗:一项II期临床试验

Han, Xiao; Guo, Jun; Li, Lingyu; Huang, Yong; Meng, Xue; Wang, Linlin; Zhu, Hui; Meng, Xiangjiao; Shao, Qian; Li, Xing; Zhang, Yan; Wang, Jin; Chen, Yanhua; Zhang, Yingjie; Chen, Yiru; Zhu, Changbin; Wang, Zhehai

Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS)

奥莫替尼与吉非替尼治疗未经治疗的 EGFR 突变晚期非小细胞肺癌患者的中枢神经系统疗效:一项随机 III 期试验 (AENEAS) 的数据

Lu, Shun; Dong, Xiaorong; Jian, Hong; Chen, Jianhua; Chen, Gongyan; Sun, Yuping; Ji, Yinghua; Wang, Ziping; Shi, Jianhua; Lu, Junguo; Chen, Shaoshui; Lv, Dongqing; Zhang, Guojun; Liu, Chunling; Li, Juan; Yu, Xinmin; Lin, Zhong; Yu, Zhuang; Wang, Zhehai; Cui, Jiuwei; Xu, Xingxiang; Fang, Jian; Feng, Jifeng; Xu, Zhi; Ma, Rui; Hu, Jie; Yang, Nong; Zhou, Xiangdong; Wu, Xiaohong; Hu, Chengping; Zhang, Zhihong; Lu, You; Hu, Yanping; Jiang, Liyan; Wang, Qiming; Guo, Renhua; Zhou, Jianying; Li, Baolan; Hu, Chunhong; Tong, Wancheng; Zhang, Helong; Ma, Lin; Chen, Yuan; Jie, Zhijun; Yao, Yu; Zhang, Longzhen; Weng, Jie; Li, Weidong; Xiong, Jianping; Ye, Xianwei; Duan, Jianchun; Yang, Haihua; Sun, Meili; Wei, Hongying; Wei, Jiawei; Zhang, Zheyu; Wu, Qiong

Camrelizumab plus carboplatin and pemetrexed as first-line therapy for advanced non-squamous non-small-cell lung cancer: 5-year outcomes of the CameL randomized phase 3 study

卡瑞利珠单抗联合卡铂和培美曲塞作为晚期非鳞状非小细胞肺癌一线治疗:CameL随机3期研究的5年结果

Zhou, Caicun; Chen, Gongyan; Huang, Yunchao; Zhou, Jianying; Lin, LiZhu; Feng, Jifeng; Wang, Zhehai; Shu, Yongqian; Shi, Jianhua; Hu, Yi; Wang, QiMing; Cheng, Ying; Wu, Fengying; Chen, Jianhua; Lin, Xiaoyan; Wang, Yongsheng; Huang, Jianan; Cui, Jiuwei; Cao, Lejie; Liu, Yunpeng; Zhang, Yiping; Pan, Yueyin; Zhao, Jun; Wang, LiPing; Chang, Jianhua; Chen, Qun; Ren, Xiubao; Zhang, Wei; Fan, Yun; He, Zhiyong; Fang, Jian; Gu, Kangsheng; Dong, XiaoRong; Jin, Faguang; Gao, Hongjun; An, Guangyu; Ding, Cuimin; Jiang, Xiaodong; Xiong, Jianping; Zhou, Xiangdong; Hu, Sheng; Lu, Ping; Liu, Anwen; Guo, Shuliang; Huang, Jianjin; Zhu, Chengchu; Zhao, Jian; Gao, Beili; Chen, Yinglan; Hu, Chengping; Zhang, Jian; Zhang, Hongmei; Zhao, Hui; Wang, Zhigao; Ma, Xinjing; Shi, Wei

Efficacy, safety, and quality of life of dabrafenib plus trametinib treatment in Chinese patients with BRAF (V600E) mutation-positive metastatic non-small cell lung cancer

达拉非尼联合曲美替尼治疗BRAF(V600E)突变阳性转移性非小细胞肺癌中国患者的疗效、安全性和生活质量

Fan, Yun; Zhou, Jianying; Zhao, Yuanyuan; Yu, Yan; Yang, Nong; Li, Juan; Wang, Jialei; Zhao, Jun; Wang, Zhehai; Chen, Jun; Zhu, Tong; Li, Haifu; Passos, Vanessa Q; Bury-Maynard, Denise; Zhang, Li

Efficacy of immunotherapy in HER2-mutated non-small cell lung cancer: a single-arm meta-analysis

免疫疗法治疗HER2突变型非小细胞肺癌的疗效:一项单臂荟萃分析

Zhang, Juguang; Han, Weizhong; Guo, Jun; Zhang, Chufeng; Cao, Lijun; Peng, Lixiu; Han, Xiao; Wang, Zhehai